Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleThe best of both worlds.AuthorsSmaglik, PaulAbstractFocuses on the changes in ownership of biotechnological firms in Seattle, Washington. Merck & Co. Inc.'s acquisition of Rosetta Inpharmatics Inc.; Amgen Inc.'s purchase of Immunex Corp.; Convergence of information technology and biotechnology.SubjectsWASHINGTON (State); SEATTLE (Wash.); UNITED States; BIOTECHNOLOGY industries; ROSETTA Inpharmatics LLC; MERCK &; Co. Inc.; IMMUNEX Corp.; AMGEN Inc.PublicationNature, 2002, Vol 417, Issue 6889, p4ISSN0028-0836Publication typeArticleDOI10.1038/nj6889-04a